These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 9736177)
1. Three paediatric cases of primary sclerosing cholangitis treated with ursodeoxycholic acid and sulphasalazine. Kozaiwa K; Tajiri H; Sawada A; Tada K; Etani Y; Miki K; Okada S J Gastroenterol Hepatol; 1998 Aug; 13(8):825-9. PubMed ID: 9736177 [TBL] [Abstract][Full Text] [Related]
2. Combined therapy with azathioprine, prednisolone, and ursodiol in patients with primary sclerosing cholangitis. A case series. Schramm C; Schirmacher P; Helmreich-Becker I; Gerken G; zum Büschenfelde KH; Lohse AW Ann Intern Med; 1999 Dec; 131(12):943-6. PubMed ID: 10610645 [TBL] [Abstract][Full Text] [Related]
3. Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis: Predictors of Gamma Glutamyltransferase Normalization and Favorable Clinical Course. Deneau M; Perito E; Ricciuto A; Gupta N; Kamath BM; Palle S; Vitola B; Smolka V; Ferrari F; Amir AZ; Miloh T; Papadopoulou A; Mohan P; Mack C; Kolho KL; Iorio R; El-Matary W; Venkat V; Chan A; Saubermann L; Valentino PL; Shah U; Miethke A; Lin H; Jensen MK J Pediatr; 2019 Jun; 209():92-96.e1. PubMed ID: 30878206 [TBL] [Abstract][Full Text] [Related]
4. Paradoxical progression of biliary strictures against recovery of biochemical parameters under ursodeoxycholic acid treatment in a case of primary sclerosing cholangitis with ulcerative colitis. Komatsu K; Shimosegawa T; Kikuchi S; Uchi M; Maruhama Y; Kisara N; Ueno Y; Toyota T Intern Med; 2000 Dec; 39(12):1049-53. PubMed ID: 11197788 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of ursodeoxycholic acid in the treatment of primary sclerosing cholangitis in children. Gilger MA; Gann ME; Opekun AR; Gleason WA J Pediatr Gastroenterol Nutr; 2000 Aug; 31(2):136-41. PubMed ID: 10941964 [TBL] [Abstract][Full Text] [Related]
6. Effectiveness of Ursodeoxycholic Acid in the Treatment of Primary Sclerosing Cholangitis with Ulcerative Colitis: A Pediatric Case. Fujita Y; Sugaya T; Inui A; Yoshihara S Tohoku J Exp Med; 2021 Feb; 253(2):109-112. PubMed ID: 33551380 [TBL] [Abstract][Full Text] [Related]
7. Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis: a randomized placebo-controlled trial. Färkkilä M; Karvonen AL; Nurmi H; Nuutinen H; Taavitsainen M; Pikkarainen P; Kärkkäinen P Hepatology; 2004 Dec; 40(6):1379-86. PubMed ID: 15565569 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic benefit of sulfasalazine for patients with primary sclerosing cholangitis. Tada S; Ebinuma H; Saito H; Hibi T J Gastroenterol; 2006 Apr; 41(4):388-9. PubMed ID: 16741620 [No Abstract] [Full Text] [Related]
9. Effect of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis. A 3-year pilot study with a placebo-controlled study period. Stiehl A; Walker S; Stiehl L; Rudolph G; Hofmann WJ; Theilmann L J Hepatol; 1994 Jan; 20(1):57-64. PubMed ID: 8201224 [TBL] [Abstract][Full Text] [Related]
10. Mucin-producing carcinoma of the gallbladder associated with primary sclerosing cholangitis and ulcerative colitis. Noda H; Chiba F; Toyama N; Konishi F J Hepatobiliary Pancreat Surg; 2009; 16(1):83-5. PubMed ID: 19096754 [TBL] [Abstract][Full Text] [Related]
11. A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis. Mitchell SA; Bansi DS; Hunt N; Von Bergmann K; Fleming KA; Chapman RW Gastroenterology; 2001 Oct; 121(4):900-7. PubMed ID: 11606503 [TBL] [Abstract][Full Text] [Related]
13. Autoimmune hepatitis 2 years after the diagnosis of primary sclerosing cholangitis: an unusual overlap syndrome in a 17-year-old adolescent. Mueller T; Bianchi L; Menges M Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):232-6. PubMed ID: 18301306 [TBL] [Abstract][Full Text] [Related]
14. Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial. Beuers U; Spengler U; Kruis W; Aydemir U; Wiebecke B; Heldwein W; Weinzierl M; Pape GR; Sauerbruch T; Paumgartner G Hepatology; 1992 Sep; 16(3):707-14. PubMed ID: 1505913 [TBL] [Abstract][Full Text] [Related]
15. Primary sclerosing cholangitis in a child. Lin WT; Lin SJ; Ni YH; Chen HL; Wang HP; Chu JS; Chang MH J Formos Med Assoc; 1999 Mar; 98(3):209-13. PubMed ID: 10365542 [TBL] [Abstract][Full Text] [Related]
16. Overlap syndrome between autoimmune hepatitis and primary sclerosing cholangitis in two cases. Griga T; Tromm A; Müller KM; May B Eur J Gastroenterol Hepatol; 2000 May; 12(5):559-64. PubMed ID: 10833101 [TBL] [Abstract][Full Text] [Related]
17. Prospective evaluation of ursodeoxycholic acid withdrawal in patients with primary sclerosing cholangitis. Wunsch E; Trottier J; Milkiewicz M; Raszeja-Wyszomirska J; Hirschfield GM; Barbier O; Milkiewicz P Hepatology; 2014 Sep; 60(3):931-40. PubMed ID: 24519384 [TBL] [Abstract][Full Text] [Related]